- New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition
-
We describe new synthetic routes developed toward a range of substituted analogues of bromo and extra-terminal (BET) bromodomain inhibitors I-BET762/JQ1 based on the triazolo-benzodiazepine scaffold. These new routes allow for the derivatization of the me
- Baud, Matthias G. J.,Lin-Shiao, Enrique,Zengerle, Michael,Tallant, Cynthia,Ciulli, Alessio
-
p. 1492 - 1500
(2016/03/08)
-
- BENZODIAZEPINE BROMODOMAIN INHIBITOR
-
Benzodiazepine compounds of formula (I), and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy, in particular in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated.
- -
-
Page/Page column 75; 77
(2011/06/11)
-
- Discovery and characterization of small molecule inhibitors of the BET family bromodomains
-
Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes. An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains. While the biological and structural characterization of many bromodomain containing proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood. This paper describes the discovery and molecular characterization of potent (nM) small molecule inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4). By using a combination of phenotypic screening, chemoproteomics, and biophysical studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small molecules that bind at the acetylated lysine recognition pocket. X-ray crystal structures of compounds bound into bromodomains of Brd2 and Brd4 elucidate the molecular interactions of binding and explain the precisely defined stereochemistry required for activity.
- Chung, Chun-Wa,Coste, Hervé,White, Julia H.,Mirguet, Olivier,Wilde, Jonathan,Gosmini, Romain L.,Delves, Chris,Magny, Sylvie M.,Woodward, Robert,Hughes, Stephen A.,Boursier, Eric V.,Flynn, Helen,Bouillot, Anne M.,Bamborough, Paul,Brusq, Jean-Marie G.,Gellibert, Franc-Oise J.,Jones, Emma J.,Riou, Alizon M.,Homes, Paul,Martin, Sandrine L.,Uings, Iain J.,Toum, Jér?me,Clément, Catherine A.,Boullay, Anne-Bénédicte,Grimley, Rachel L.,Blandel, Florence M.,Prinjha, Rab K.,Lee, Kevin,Kirilovsky, Jorge,Nicodeme, Edwige
-
supporting information; experimental part
p. 3827 - 3838
(2011/08/07)
-